ProKidney Corp.
PROK
$1.08
$0.054.85%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -4.30% | -9.18% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 18.32% | 1.38% | |||
| Operating Income | -18.15% | -1.38% | |||
| Income Before Tax | -7.80% | -12.65% | |||
| Income Tax Expenses | 172.67% | -4,082.14% | |||
| Earnings from Continuing Operations | -18.10% | -6.73% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 17.55% | -10.85% | |||
| Net Income | -18.81% | -43.21% | |||
| EBIT | -18.15% | -1.38% | |||
| EBITDA | -18.58% | -0.90% | |||
| EPS Basic | -16.98% | 13.90% | |||
| Normalized Basic EPS | -205.77% | -120.97% | |||
| EPS Diluted | -16.98% | 13.90% | |||
| Normalized Diluted EPS | -205.77% | -120.97% | |||
| Average Basic Shares Outstanding | 1.61% | 66.22% | |||
| Average Diluted Shares Outstanding | 1.61% | 66.22% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||